Using technology to improve cognitive function in older adults
Effect of Screen Based Cognitove Therapy on Mild Dementi in Elderly
NA · Cairo University · NCT06378606
This study tests whether using interactive video games and mobile apps can help improve thinking skills in older adults with mild dementia.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 65 Years to 85 Years |
| Sex | All |
| Sponsor | Cairo University (other) |
| Locations | 1 site (Cairo, Giza) |
| Trial ID | NCT06378606 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of cognitive technology therapies, such as interactive video gaming and mobile applications, on cognitive function in elderly individuals aged 65 and older with mild dementia. The approach focuses on non-pharmacological interventions to enhance cognitive training and rehabilitation, aiming to address the decline in cognitive abilities associated with aging. By utilizing accessible and cost-effective technology, the study seeks to provide immersive experiences that may improve cognitive outcomes for participants. The study is particularly relevant given the increasing prevalence of dementia and the need for effective preventive strategies.
Who should consider this trial
Good fit: Ideal candidates for this study are older adults aged 65 and above with mild dementia who are literate and have access to an Android smartphone.
Not a fit: Patients with severe cognitive dementia, major cardiovascular events, or significant communication limitations may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could offer a novel, non-drug approach to slowing cognitive decline in older adults.
How similar studies have performed: Other studies have shown promise in using technology-based interventions for cognitive training, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria 1- Age ≥ 65 years. 2- Literate with ≥ 15 years of education. 3- Older adults with mild dementia. 4- Montreal cognitive assessment score 18-26 .( Pinto et al .,2019). 5- Android smartphone user. 6- Well ability to write and read. Exclusion criteria 1. Major Cardiovascular events , such as Stroke or Myocardial infraction in past three months. 2. Alzheimer's disease. 3. Sever cognitive dementia. 4. Sever hearing difficulty or visual disturbance. 5. Brain injury. 6. Limitation in communications. 7. Chronic kidney diseases. 8. Liver diseases. 9. Low or high educated. 10. Uncontrolled diabetic patients. 11. Thyroid disturbance. 12. Mental and psychological instability .
Where this trial is running
Cairo, Giza
- Nour Ali — Cairo, Giza, Egypt (RECRUITING)
Study contacts
- Study coordinator: nourhan hisham ali
- Email: nourheshame854@gmail.com
- Phone: 01156860154
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cognitive Impairment